NSYS (Nortech Systems Inc) Stock Analysis - Hedge Fund Holdings
Nortech Systems Inc (NSYS) is a publicly traded Technology sector company. As of May 21, 2026, NSYS trades at $12.40 with a market cap of $34.62M and a P/E ratio of 32.59. NSYS moved +0.00% today. Year to date, NSYS is +67.94%; over the trailing twelve months it is +33.98%. Its 52-week range spans $6.50 to $15.39. Rallies surfaces NSYS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns NSYS stock?
Hedge funds tracked by Rallies that own NSYS include Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Nortech Systems Inc.
NSYS Key Metrics
Key financial metrics for NSYS
Metric
Value
Price
$12.40
Market Cap
$34.62M
P/E Ratio
32.59
EPS
$0.38
Dividend Yield
0.00%
52-Week High
$15.39
52-Week Low
$6.50
Volume
0
Avg Volume
0
Revenue (TTM)
$72.55M
Net Income
$1.03M
Gross Margin
27.06%
Top Hedge Funds Holding NSYS
Renaissance Technologies holds 54.20K shares of NSYS, changed -4.58% as of Dec 31, 2024.
KUNIN DAVID B bought 21 (~$248.789) on Mar 22, 2023.
KUNIN DAVID B bought 302 (~$3.68K) on Mar 21, 2023.
KUNIN DAVID B bought 1.63K (~$19.41K) on Mar 20, 2023.
NSYS Analyst Consensus
NSYS analyst coverage data. Average price target: $0.00.
Common questions about NSYS
Who owns NSYS stock?
Hedge funds tracked by Rallies that own NSYS include Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Nortech Systems Inc.
Does Rallies show 13F holders for NSYS?
Yes. Rallies tracks hedge fund and 13F ownership data for NSYS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is NSYS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NSYS. It does not provide personalized investment advice.